Key facts
- Notable investors include Leaguer Financial, Leaguer Angel, Yixi Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for MAGTEIN
- ·The full record, as it builds
Funding rounds
No funding rounds for MAGTEIN are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MAGTEIN
Developer of a patented magnesium compound designed to enhance brain magnesium levels for improved cognitive function and mental clarity. The company offers a proprietary form of magnesium L-threonate, capable of crossing the blood-brain barrier, enabling consumers and healthcare providers to support memory, focus, mood balance, and brain health through scientifically backed neuroprotective benefits.
- Sector
- Healthcare
- HQ
- Wuxi, China
- Founded
- 2013
- Employees
- 11
- Website
- magtein.com/
- Ownership
- Privately Held (backing)
MAGTEIN doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MAGTEIN shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MAGTEIN in its N-PORT filings yet. We sweep new filings monthly.